Diversified Trust CO Medpace Holdings, Inc. Transaction History

Diversified Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$372.0 - $424.34 $155,124 - $176,949	-417 Reduced 23.53%	1,355 $558,000
Q1 2024 Apr 18, 2024	SELL	$284.87 - $413.31 $172,631 - $250,465	-606 Reduced 25.48%	1,772 $716,000
Q4 2023 Jan 08, 2024	SELL	$227.52 - $312.68 $682 - $938	-3 Reduced 0.13%	2,378 $728,000
Q3 2023 Nov 17, 2023	BUY	$233.98 - $281.67 $701 - $845	3 Added 0.13%	2,381 $576,000
Q2 2023 Jul 18, 2023	BUY	$187.26 - $240.17 $138,946 - $178,206	742 Added 45.35%	2,378 $571,000
Q1 2023 Apr 07, 2023	BUY	$174.31 - $239.52 $93,430 - $128,382	536 Added 48.73%	1,636 $307,000
Q4 2022 Jan 17, 2023	BUY	$153.06 - $226.57 $168,366 - $249,227	1,100 New	1,100 $234,000

628

25.1M

38.7K

64.7K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $11B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.